Healthcare -
Biotechnology - NASDAQ - US
$ 31.47
-6.08 %
$ 2.89 B
Market Cap
-32.68
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Legend Biotech Corporation
| Revenue | 627 M |
| Cost Of Revenue | 235 M |
| Gross Profit | 393 M |
| Operating Expenses | 696 M |
| Operating Income | -303 M |
| Other Expenses | -145 M |
| Net Income | -158 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Revenue | 627.2 | 285.1 | 117.0 | 89.8 | 75.7 | 57.3 | 49.1 | 23.6 |
| GROSS PROFIT | ||||||||
| Cost Of Revenue | 234.6 | 144.2 | 65.4 | 313.3 | 232.2 | 0 | 0 | 96 K |
| Gross Profit | 392.7 | 140.9 | 51.6 | (223.6) | (156.5) | 57.3 | 49.1 | 23.7 |
| OPERATING INCOME | ||||||||
| Operating Expenses | 695.9 | 140.9 | 509.7 | 462.8 | 304.9 | 192.6 | 64.2 | 9.6 |
| Selling, General and Administrative Expenses | 284.3 | 200.9 | 174.0 | 149.5 | 72.7 | 32.4 | 3.9 | 1.4 |
| Research and Development Expenses | 413.5 | 382.2 | 335.6 | 313.3 | 232.2 | 161.9 | 60.6 | 8.2 |
| Operating Income | (303.2) | (439.5) | (455.8) | (393.0) | (313.3) | (130.9) | (1.5) | 13.8 |
| PRE-TAX INCOME | ||||||||
| Interest Income Expense | 21.6 | 21.8 | 10.8 | 0.9 | 4.2 | 0.2 | 82 K | 0 |
| Total Other Income | 145.1 | (80.6) | 10.1 | (14.2) | (78.4) | 5.0 | 13.5 | 40 K |
| Pre-Tax Income | (158.1) | (520.1) | (445.7) | (386.2) | (307.6) | (130.4) | (1.6) | 13.8 |
| NET INCOME | ||||||||
| Tax Provision | 18.9 | (1.9) | 0.6 | 1 K | (4.1) | 2.6 | 1.2 | 4.5 |
| Net Income | (177.0) | (518.3) | (446.3) | (386.2) | (303.5) | (133.0) | (2.8) | 9.4 |
| EPS | 1.94 | 5.88 | 5.62 | 5.48 | 5.14 | 2.02 | 0.0556 | 0.14 |